Healthcare provider profile · identity verified

John Jeffrey Monda

Family Practice · WENATCHEE, WA · NPI 1477042570

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	625	181
Lisinopril	Lisinopril	477	135
Amlodipine Besylate	Amlodipine Besylate	381	106
Losartan Potassium	Losartan Potassium	307	89
Omeprazole	Omeprazole	306	93
Levothyroxine Sodium	Levothyroxine Sodium	242	62
Tamsulosin Hcl	Tamsulosin Hcl	230	66
Metoprolol Succinate	Metoprolol Succinate	224	64
Rosuvastatin Calcium	Rosuvastatin Calcium	190	52
Hydrochlorothiazide	Hydrochlorothiazide	174	54
Metformin Hcl	Metformin Hcl	166	44
Trazodone Hcl	Trazodone Hcl	143	47
Potassium Chloride	Potassium Chloride	137	46
Gabapentin	Gabapentin	127	44
Simvastatin	Simvastatin	120	35
Albuterol Sulfate Hfa	Albuterol Sulfate	106	43
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	103	15
Sertraline Hcl	Sertraline Hcl	103	31
Furosemide	Furosemide	86	32
Ozempic	Semaglutide	85	11
Metformin Hcl Er	Metformin Hcl	82	29
Oxycodone Hcl	Oxycodone Hcl	78	13
Pravastatin Sodium	Pravastatin Sodium	77	22
Allopurinol	Allopurinol	72	20
Tramadol Hcl	Tramadol Hcl	71	14
Famotidine	Famotidine	67	15
Methocarbamol	Methocarbamol	58	25
Venlafaxine Hcl Er	Venlafaxine Hcl	58	12
Alendronate Sodium	Alendronate Sodium	55	15
Finasteride	Finasteride	54	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	50	12
Fluticasone Propionate	Fluticasone Propionate	49	18
Metoprolol Tartrate	Metoprolol Tartrate	49	17
Citalopram Hbr	Citalopram Hydrobromide	48	14
Jardiance	Empagliflozin	48	suppressed
Carvedilol	Carvedilol	47	12
Paroxetine Hcl	Paroxetine Hcl	47	suppressed
Bupropion Xl	Bupropion Hcl	46	13
Triamcinolone Acetonide	Triamcinolone Acetonide	46	27
Atenolol	Atenolol	45	12
Benazepril Hcl	Benazepril Hcl	45	12
Montelukast Sodium	Montelukast Sodium	45	13
Zolpidem Tartrate	Zolpidem Tartrate	45	11
Duloxetine Hcl	Duloxetine Hcl	44	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	11
Spironolactone	Spironolactone	42	17
Fluoxetine Hcl	Fluoxetine Hcl	41	11
Pantoprazole Sodium	Pantoprazole Sodium	41	13
Methadone Hcl	Methadone Hcl	40	suppressed
Baclofen	Baclofen	39	suppressed
Olanzapine	Olanzapine	39	suppressed
Diclofenac Sodium	Diclofenac Sodium	38	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	suppressed
Ezetimibe	Ezetimibe	35	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	34	suppressed
Tizanidine Hcl	Tizanidine Hcl	34	11
Chlorthalidone	Chlorthalidone	33	11
Ibuprofen	Ibuprofen	33	12
Mirtazapine	Mirtazapine	30	suppressed
Trulicity	Dulaglutide	30	suppressed
Ventolin Hfa	Albuterol Sulfate	30	suppressed
Glipizide	Glipizide	28	11
Ondansetron Odt	Ondansetron	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Glipizide Er	Glipizide	27	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	25	suppressed
Lorazepam	Lorazepam	24	suppressed
Arnuity Ellipta	Fluticasone Furoate	23	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Alprazolam	Alprazolam	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Lovastatin	Lovastatin	20	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	20	suppressed
Risperidone	Risperidone	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Bumetanide	Bumetanide	17	suppressed
Clonazepam	Clonazepam	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Prednisone	Prednisone	17	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Sulfasalazine	Sulfasalazine	16	suppressed
Diazepam	Diazepam	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Topiramate	Topiramate	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Mupirocin	Mupirocin	14	11
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Letrozole	Letrozole	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Exemestane	Exemestane	12	suppressed
Ketoconazole	Ketoconazole	12	11
Naproxen	Naproxen	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Nystatin	Nystatin	12	suppressed
Serevent Diskus	Salmeterol Xinafoate	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Cephalexin	Cephalexin	11	11
Clonidine Hcl	Clonidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error